Novartis (NYSE: NVS) announced today that the US Food and Drug Administration (FDA) approved the use of Flucelvax® (Influenza Virus ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE